Swiss Prime Site AG (FRA:SU1N)

Blueprint Medicines Statistics

Total Valuation

FRA:SU1N has a market cap or net worth of EUR 9.72 billion. The enterprise value is 15.68 billion.

Market Cap	9.72B
Enterprise Value	15.68B

Important Dates

The next estimated earnings date is Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	Mar 21, 2025

Share Statistics

Current Share Class	80.23M
Shares Outstanding	n/a
Shares Change (YoY)	-0.84%
Shares Change (QoQ)	-7.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	80.11M

Valuation Ratios

The trailing PE ratio is 25.32 and the forward PE ratio is 31.09.

Price/FFO Ratio	29.97
Price/AFFO Ratio	n/a
PE Ratio	25.32
Forward PE	31.09
PS Ratio	13.60
PB Ratio	1.37
P/TBV Ratio	1.44
P/FCF Ratio	22.61
P/OCF Ratio	22.59
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.15, with an EV/FCF ratio of 36.47.

EV / Earnings	40.84
EV / Sales	21.72
EV / EBITDA	34.15
EV / EBIT	34.80
EV / FCF	36.47

Financial Position

The company has a current ratio of 0.20, with a Debt / Equity ratio of 0.83.

Current Ratio	0.20
Quick Ratio	0.06
Debt / Equity	0.83
Debt / EBITDA	13.03
Debt / FCF	13.78
Interest Coverage	6.02

Financial Efficiency

Return on equity (ROE) is 5.45% and return on invested capital (ROIC) is 2.14%.

Return on Equity (ROE)	5.45%
Return on Assets (ROA)	1.89%
Return on Invested Capital (ROIC)	2.14%
Return on Capital Employed (ROCE)	3.34%
Revenue Per Employee	1.32M
Profits Per Employee	709,781
Employee Count	570
Asset Turnover	0.05
Inventory Turnover	5.86

Taxes

In the past 12 months, FRA:SU1N has paid 89.97 million in taxes.

Income Tax	89.97M
Effective Tax Rate	18.98%

Stock Price Statistics

The stock price has increased by +61.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+61.12%
50-Day Moving Average	123.85
200-Day Moving Average	90.99
Relative Strength Index (RSI)	30.89
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:SU1N had revenue of EUR 715.17 million and earned 383.99 million in profits. Earnings per share was 4.81.

Revenue	715.17M
Gross Profit	571.98M
Operating Income	446.27M
Pretax Income	473.96M
Net Income	383.99M
EBITDA	451.17M
EBIT	446.27M
Earnings Per Share (EPS)	4.81

Balance Sheet

The company has 25.55 million in cash and 5.93 billion in debt, giving a net cash position of -5.90 billion.

Cash & Cash Equivalents	25.55M
Total Debt	5.93B
Net Cash	-5.90B
Net Cash Per Share	n/a
Equity (Book Value)	7.12B
Book Value Per Share	92.07
Working Capital	-1.11B

Cash Flow

In the last 12 months, operating cash flow was 430.40 million and capital expenditures -377,330, giving a free cash flow of 430.03 million.

Operating Cash Flow	430.40M
Capital Expenditures	-377,330
Free Cash Flow	430.03M
FCF Per Share	n/a

Margins

Gross margin is 79.98%, with operating and profit margins of 62.40% and 53.69%.

Gross Margin	79.98%
Operating Margin	62.40%
Pretax Margin	66.27%
Profit Margin	53.69%
EBITDA Margin	63.09%
EBIT Margin	62.40%
FCF Margin	60.13%

Dividends & Yields

This stock pays an annual dividend of 3.45, which amounts to a dividend yield of 2.86%.

Dividend Per Share	3.45
Dividend Yield	2.86%
Dividend Growth (YoY)	1.47%
Years of Dividend Growth	n/a
Payout Ratio	72.41%
Buyback Yield	0.84%
Shareholder Yield	3.70%
Earnings Yield	3.95%
FCF Yield	4.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5